Overview Safety and Efficacy Study of MK0974 in the Acute Migraine (0974-016) Status: Completed Trial end date: 2007-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to investigate the efficacy and safety of MK0974 compared to a placebo for acute migraine. Phase: Phase 3 Details Lead Sponsor: Merck Sharp & Dohme Corp.